Showing 1 - 20 results of 35 for search 'PHARMACOECONOMICS', query time: 0.47s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
    by Lorenzo Pradelli, Mario Eandi
    Published 2007-06-01
    ... impact of CINV are reviewed, as well as national pharmacoeconomic evalutations conducted on palonosetron...
    Get full text
    Article
  6. 6
  7. 7
  8. 8
    by Mario Eandi
    Published 2008-03-01
    Subjects: ...pharmacoeconomics...
    Get full text
    Article
  9. 9
    by Mario Eandi
    Published 2009-03-01
    Subjects: ...pharmacoeconomics...
    Get full text
    Article
  10. 10
  11. 11
    by Mario Eandi
    Published 2012-03-01
    Subjects: ...pharmacoeconomics...
    Get full text
    Article
  12. 12
    by Nicola Giotta, Ercole Biamino, Mario Eandi
    Published 2007-06-01
    ...The main aim of this retrospective study was to perform a pharmacoeconomic analysis of long term...
    Get full text
    Article
  13. 13
  14. 14
    by Mario Eandi
    Published 2001-09-01
    ...In this study we mean to outline a brief pharmacoeconomic review of fluvoxamine, considering only...
    Get full text
    Article
  15. 15
    by Federica Mathis, Lorenzo Pradelli, Mario Eandi
    Published 2004-12-01
    ... is to describe the pharmacoeconomical profile of the drug in the Italian setting, focusing on the comparison...
    Get full text
    Article
  16. 16
    by Mario Eandi, Carlo Della Pepa
    Published 2001-12-01
    ... of resistant strains of Pseudomonas aeruginosa; V) review of pharmacoeconomic data of different antibacterial...
    Get full text
    Article
  17. 17
    by Sergio Iannazzo, Lorenzo Pradelli, Mario Eandi
    Published 2005-12-01
    ... pharmacoeconomic model based on clinical data from DAVID and national economic parameters and demographics...
    Get full text
    Article
  18. 18
    by Mario Eandi
    Published 2002-03-01
    ... are reviewed and analysed under the pharmacoeconomic perspectives of the italian patients, General...
    Get full text
    Article
  19. 19
    by Mario Eandi
    Published 2011-06-01
    ... in the disease progression. If compared, through pharmacoeconomic models and analysis, to tenofovir, a nucleotide...
    Get full text
    Article
  20. 20
    by Lorenzo Pradelli, Mario Eandi
    Published 2003-03-01
    .... Starting from these clinical data, the second part outlines the pharmacoeconomical profile of the drug...
    Get full text
    Article